Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. — Stella

Home/Malaria,Falciparum/A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

View on ClinicalTrials.gov

Recruiting

Back to Malaria,Falciparum trials

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Burkina Faso

Institut de Recherche en Sciences de la Santé, Siglé, Boulkiemdé Province

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Oxford

Collaborators

Institut de Recherche en Sciences de la Sante, Burkina Faso, European and Developing Countries Clinical Trials Partnership (EDCTP)

Enrollment target

~480 participants

Started

April 2023

Primary completion

May 2026

Age range

5 Months – 17 Months

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.